Main Management ETF Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-21,141
Closed -$1.85M 144
2025
Q4
$1.85M Buy
21,141
+216
+1% +$16.4K 0.07% 58
2025
Q3
$1.2M Buy
+20,925
New +$1.2M 0.04% 95

Other funds holding GMED

Main Management ETF Advisors's GMED Position: Q1 2026 in Review

Main Management ETF Advisors sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 21,141 shares — an estimated $1.85M sold.

Main Management ETF Advisors first reported a position in GMED in Q3 2025 and held it in 2 quarters. The position peaked at $1.85M in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Main Management ETF Advisors reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • Main Management ETF Advisors sold 21,141 Globus Medical shares in Q1 2026, an estimated $1.85M.
  • Main Management ETF Advisors first reported a position in Globus Medical in Q3 2025 and held it in 2 quarters.
  • Main Management ETF Advisors's Globus Medical position peaked at $1.85M in Q4 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Main Management ETF Advisors's 13F filing for Q1 2026, filed 15 May 2026.